Akathisia Variants and Tardive Dyskinesia

Archives of General Psychiatry

Volumn 42, Issue 9, 1985, Pages 874-878

  Barnes, Thomas R E ^a,b   Braude, Walter M ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM CARBONATE; NEUROLEPTIC AGENT;

ADVERSE DRUG REACTION; AKATHISIA; CENTRAL NERVOUS SYSTEM; DRUG THERAPY; EXTRAPYRAMIDAL SYMPTOM; HEMOLEPTIC AGENT; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; NERVOUS SYSTEM; NEUROTOXICITY; PRIORITY JOURNAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA; THERAPY;

ADULT; AGED; AKATHISIA, DRUG-INDUCED; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMAN; MALE; MIDDLE AGE; PSYCHOMOTOR AGITATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, NON-U.S. GOV'T;

EID: 0022356785     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1985.01790320042006     Document Type: Article

References (55)

1. Haškovec L: Akathisie. Arch Bohemes Med Clin 1902;3:193-200.
2. Haškovec L: Nouvelles remarques sur l'akathisia. Nouv Iconogr Salpetriere Clin Maladies Systeme Nerv 1903;16:287-293.
3. Steck H: Le syndrome extrapyramidal et diencephalique au cours des traitments au largactil et au serpasil. Ann Med Psych 1954;112:737-743.
4. Ayd FJ: A survey of drug-induced extrapyramidal reactions. JAMA 1961;175:1054-1060.
5. Marsden CD, Tarsy D, Baldessarini RJ: Spontaneous and druginduced movement disorders in psychotic patients, in Benson DF, Blumer D (eds): Psychiatric Aspects of Neurological Disease. New York, Grune & Stratton Inc, 1975, pp 219-265.
6. Braude WM, Barnes TRE, Gore SM: Clinical characteristics of akathisia: A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry 1983;143:139-150.
7. Freyhan FA: Occurrence and management of extrapyramidal syndromes in psychiatric treatment with trifluoperazine, in Brill H (ed): Trifluoperazine, Clinical and Pharmacological Aspects. Philadelphia, Lea & Febiger, 1958.
8. Van Putten T: The many faces of akathisia. Comp Psychiatry 1975;16:43-47.
9. Yagi G, Ogita K, Ohtsuka N, Itoh H, Miura S: Persistent dyskinesia after long-term neuroleptics in Japan: Its present status and clinical problems. Keio J Med 1976;25:27-35.
10. Kalinowsky LB: Appraisal of the 'tranquilizers' and their influence on other somatic treatments in psychiatry. Am J Psychiatry 1958;115:294-298.
11. Raskin D: Akathisia: A side effect to be remembered. Am J Psychiatry 1972;129:345-347.
12. Van Putten T: Why do schizophrenics refuse to take thier drugs? Arch Gen Psychiatry 1974;31:67-72.
13. Van Putten T: Drug refusal in schizophrenia: Causes and prescribing hints. Hosp Community Psychiatry 1978;29:110-112.
14. Delay J, Deniker P: Drug-induced extrapyramidal syndromes, in Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. Amsterdam, North Holland Publishing Co, 1968, vol 6, pp 248-266.
15. Crane GE, Naranjo ER, Chase C: Motor disorders induced by neuroleptics: A proposed new classification. Arch Gen Psychiatry 1971;23:179-184.
16. Sovner R, DiMascio A: Extrapyramidal syndromes and other neurological side-effects of psychotropic drugs, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 1021-1032.
17. Kekich WA: Neuroleptics: Violence as a manifestation of akathisia. JAMA 1978;240:2185.
18. Kumar BB: An unusual case of akathisia. Am J Psychiatry 1979;136:1088.
19. Friis T, Behnke K, Rosted Kristensen T, Gerlach J: Sodium valproate (a GABA agonist) and biperiden (an anticholinergic drug) in akathisia, abstract F143. Abstracts of the III World Congress of Biological Psychiatry, Stockholm, June 28-July 3, 1981.
20. Jenner P, Marsden CD: Antiparkinsonian and antidyskinetic drugs, in Tyrer PG (ed): Drugs in Psychiatric Practice. London, Butterworth, 1982, pp 82-125.
21. Faurbye A, Rasch PJ, Peterson PB, Brandborg G, Pakkenberg H: Neurological symptoms in phamacotherapy of psychoses. Acta Psychiatr Scand 1964;40:10-27.
22. Brandon S, McClelland MA, Prothroe C: A study of facial dyskinesia in a mental hospital population. Br J Psychiatry 1971;118:171-184.
23. Kennedy PF, Hershon HI, McGuire RJ: Extrapyramidal disorders after prolonged phenothiazine therapy. Br J Psychiatry 1971;118:509-518.
24. Wojcik JD, Gelenberg AJ, La Brie RA, Mieske M: Prevalence of tardive dyskinesia in an outpatient population. Comp Psychiatry 1980;21:370-380.
25. Chouinard G, Annable L, Ross-Chouinard A: Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: Extrapyramidal symptoms and therapeutic effect. Am J Psychiatry 1982;139:312-318.
26. Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S: Tardive dyskinesia in psychiatric outpatients. Arch Gen Psychiatry 1982;39:466-469.
27. Barnes TRE, Kidger T, Gore SM: Tardive dyskinesia: A three-year, follow-up study. Psychol Med 1983;13:71-81.
28. Mackay AVP: Clinical controversies in tardive dyskinesia, in Marsden CD, Fahn S (eds): Neurology. London, Butterworth, 1982, vol 2: Movement Disorders, pp 249-262.
29. Kidger T, Barnes TRE, Trauer T, Taylor PJ: Sub-syndromes of tardive dyskinesia. Psychol Med 1980;10:513-520.
30. Granacher RP: Differential diagnosis of tardive dyskinesia: An overview. Am J Psychiatry 1981;138:1288-1297.
31. Bobruff A, Gardos G, Tarsy D, Rapkin RM, Cole JO, Moore P: Clonazepam and phenobarbital in tardive dyskinesia. Am J Psychiatry 1981;138:189-193.
32. Barnes TRE, Rossor M, Trauer T: A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals. J Neurol Neurosurg Psychiatry 1983;46:540-546.
33. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
34. Krawiecka M, Goldberg D, Vaughan M: A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977;55:299-308.
35. Johnstone EC, Owens DGC, Gold A, Crow TJ, Macmillan JF: Institutionalization and the defects of schizophrenia. Br J Psychiatry 1981;139:195-203.
36. Simpson GM, Angus JWS: A rating scale for extrapyramidal sideeffects. Acta Psychiatr Scand 1970;212(suppl 44):11-19.
37. Barnes TRE, Trauer T: Reliability and validity of a tardive dyskinesia videotape rating technique. Br J Psychiatry 1982;140:508-515.
38. Research Group on Extrapyramidal Disorders of the World Federation of Neurology: Classification of extrapyramidal disorders: Proposal for an international classification and glossary of terms. J Neurol Sci 1981;51:311-327.
39. Ekbom KA: Asthenia crurum parasthetica (irritable legs). Acta Med Scand 1944;118:197.
40. Ekbom KA: Restless legs syndrome. Neurology 1960;10:868-873.
41. Hodge JR: Akathisia, the syndrome of motor restlessness. Am J Psychiatry 1959;116:337-338.
42. Braude WM, Charles IP, Barnes TRE: Coarse, jerky foot tremor: Tremographic investigation of an objective sign of akathisia. Psychopharmacology 1984;82:95-101.
43. Wiles DH: Tardive dyskinesia and depot fluphenazine. Br J Psychiatry 1979;135:382-383.
44. Wiles DH, Gelder MG: Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. Br J Clin Pharmacol 1979;8:565-570.
45. Jørgensen A: Pharmacokinetic studies in volunteers of intravenous and oral cis-(z) flupentixol and intramuscular cis-(z) flupentixol decanoate in viscoleo. Eur J Clin Pharmacol 1980;18:355-360.
46. Jørgensen A, Overø KF: Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics: III. Serum levels. Acta Psychiatr Scand Suppl 1980;279:41-54.
47. Simpson GM: Neurotoxicity of major transquilizers, in Roizin L, Shiraki H, Grčević N (eds): Neurotoxicity. New York, Raven Press, 1977, vol 1, pp 1-7.
48. Munetz MR, Cornes CL: Akathisia, pseudoakathisia and tardive dyskinesia: Clinical examples. Comp Psychiatry 1982;23:345-352.
49. De Veaugh-Geiss J: Prediction and prevention of tardive dyskinesia, in De Veaugh-Geiss (ed): Tardive Dyskinesia and Related Involuntary Movement Disorders. Boston, John Wright & Sons, 1982, pp 161-166.
50. Jeste DV, Wyatt RJ: Understanding and Treating Tardive Dyskinesia. New York, Guildford Press, 1982, p 64.
51. Braude WM, Barnes TRE: Late-onset akathisia: An indicant of covert dyskinesia: Two case reports. Am J Psychiatry 1983;140:611-612.
52. Andreasen NC: Negative symptoms in schizophrenia. Arch Gen Psychiatry 1982;39:784-788.
53. Wing JK: The social context of schizophrenia. Am J Psychiatry 1978; 135:1333-1339.
54. Crow TJ: Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980;137:383-386.
55. Bing R: Textbook of Nervous Diseases, ed 5, Haymaker W (trans). London, Henry Kimpton, 1939, pp 169, 758-759.